Microbot Medical (MBOT) Accumulated Expenses (2010 - 2026)

Microbot Medical (MBOT) has 17 years of Accumulated Expenses data on file, last reported at $2.0 million in Q1 2026.

• Quarterly Accumulated Expenses rose 22.33% year-over-year to $2.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.0 million (up 22.33% YoY) and the FY2025 annual result came in at $2.6 million, up 17.48% from the prior year.
• Accumulated Expenses slipped to $2.0 million in Q1 2026, from $2.6 million in the prior quarter.
• In the past five years, Accumulated Expenses ranged from a high of $2.6 million in Q4 2025 to a low of $725000.0 in Q4 2023.
• A 5-year average of $1.4 million and a median of $1.1 million in 2022 frame the typical range for Accumulated Expenses.
• Annual changes were most pronounced in 2023 — Accumulated Expenses tumbled 56.59% — and 2024, when it soared 206.9%.
• Tracing MBOT's Accumulated Expenses over 5 years: stood at $1.7 million in 2022, then plunged by 56.59% to $725000.0 in 2023, then soared by 206.9% to $2.2 million in 2024, then advanced by 17.48% to $2.6 million in 2025, then slipped by 24.33% to $2.0 million in 2026.
• The last three Accumulated Expenses figures came in at $2.0 million (Q1 2026), $2.6 million (Q4 2025), and $2.1 million (Q3 2025), per Business Quant data.